ProMetic Life Sciences Inc (PLI) - Financial and Strategic SWOT Analysis Review

  • ID: 4278568
  • SWOT Analysis
  • 60 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Apotex Pharmachem Inc
  • Protokinetix Inc
  • MORE
ProMetic Life Sciences Inc (PLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

ProMetic Life Sciences Inc (ProMetic) is a biopharmaceutical company that focuses on bioseparations, plasma-derived therapeutics and small-molecule drug development. The company develop products for the treatment for fibrosis, anemia, autoimmune diseases, inflammation and nephropathies. The company develops drug candidates based on its two drug discovery platforms: small molecule therapeutics (PSMT) and plasma-derived therapeutics platforms. The company owns research and development facilities in the UK, the US and Canada and has manufacturing facilities in Canada and the Isle of Man. The company conducts business development activities in the US, Europe and Asia. ProMetic is headquartered in Laval, Quebec, Canada.

ProMetic Life Sciences Inc Key Recent Developments

Aug 14, 2018: Prometic Life Sciences announces second quarter 2018 financial results
May 15, 2018: Prometic Announces 2018 first quarter financial results
Apr 03, 2018: Prometic Announces Appointment of Bruce Wendel as Chief Business Development Officer
Mar 28, 2018: Prometic Reports its Q4-2017 and YE-2017 Financial Results and Provides Update on Activities
Feb 20, 2018: Prometic Announces Realignment of its Clinical Program Priorities for 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Apotex Pharmachem Inc
  • Protokinetix Inc
  • MORE
Section 1 - About the Company
ProMetic Life Sciences Inc - Key Facts
ProMetic Life Sciences Inc - Key Employees
ProMetic Life Sciences Inc - Key Employee Biographies
ProMetic Life Sciences Inc - Major Products and Services
ProMetic Life Sciences Inc - History
ProMetic Life Sciences Inc - Company Statement
ProMetic Life Sciences Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis
Company Overview
ProMetic Life Sciences Inc - Business Description
Business Segment: Bioseparations segment
Overview
Performance
Business Segment: Plasma-derived therapeutics segment
Overview
Performance
Business Segment: Small molecule therapeutics segment
Overview
Performance
Business Segment: United Kingdom
Performance
Geographical Segment: Austria
Performance
Geographical Segment: Canada
Performance
Geographical Segment: China
Performance
Geographical Segment: Korea
Performance
Geographical Segment: Netherlands
Performance
Geographical Segment: Other countries
Performance
Geographical Segment: Switzerland
Performance
Geographical Segment: United States
Performance
R&D Overview
ProMetic Life Sciences Inc - SWOT Analysis
SWOT Analysis - Overview
ProMetic Life Sciences Inc - Strengths
ProMetic Life Sciences Inc - Weaknesses
ProMetic Life Sciences Inc - Opportunities
ProMetic Life Sciences Inc - Threats
ProMetic Life Sciences Inc - Key Competitors

Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
ProMetic Life Sciences Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments
Apr 03, 2018: Prometic Announces Appointment of Bruce Wendel as Chief Business Development Officer
Mar 28, 2018: Prometic Reports its Q4-2017 and YE-2017 Financial Results and Provides Update on Activities
Feb 20, 2018: Prometic Announces Realignment of its Clinical Program Priorities for 2018
Nov 13, 2017: Prometic Reports 2017 Third Quarter Highlights and Financial Results
Aug 14, 2017: Prometic Reports 2017 Second Quarter Highlights and Financial Results
May 15, 2017: Prometic Reports 2017 First Quarter Highlights and Financial Results
May 10, 2017: Prometic reports its 2017 annual and special meeting of shareholders highlights
Apr 07, 2017: Prometic Receives $9.5 Million Purchase Order From Multinational Client
Mar 30, 2017: Prometic Reports its 2016 Fourth Quarter and Year End Highlights and Financial Results

Section 6 – Appendix
Methodology
Ratio Definitions
About
Contact Us
Disclaimer

List of Tables
ProMetic Life Sciences Inc, Key Facts
ProMetic Life Sciences Inc, Key Employees
ProMetic Life Sciences Inc, Key Employee Biographies
ProMetic Life Sciences Inc, Major Products and Services
ProMetic Life Sciences Inc, History
ProMetic Life Sciences Inc, Other Locations
ProMetic Life Sciences Inc, Subsidiaries
ProMetic Life Sciences Inc, Key Competitors
ProMetic Life Sciences Inc, Ratios based on current share price
ProMetic Life Sciences Inc, Annual Ratios
ProMetic Life Sciences Inc, Annual Ratios (Cont...1)
ProMetic Life Sciences Inc, Annual Ratios (Cont...2)
ProMetic Life Sciences Inc, Interim Ratios
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
ProMetic Life Sciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
ProMetic Life Sciences Inc, Performance Chart (2013 - 2017)
ProMetic Life Sciences Inc, Ratio Charts
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
ProMetic Life Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Transition Therapeutics Inc
  • Sterogene Bioseparations Inc
  • Protokinetix Inc
  • Apotex Pharmachem Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll